Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy
Clinical trial NCT04736576 · COMPLETED
Trial details
- NCT number
- NCT04736576
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2023-03-24
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.